The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.
暂无分享,去创建一个
Naoki Sato | Javed Butler | Stephen J. Greene | M. Vaduganathan | M. Gheorghiade | J. Butler | G. Fonarow | N. Sato | S. Nodari | C. Lam | Carolyn S.P. Lam | Muthiah Vaduganathan | Gregg C. Fonarow | Andrew P. Ambrosy | Mihai Gheorghiade | O. Chioncel | A. Ambrosy | Ami N. Shah | Ovidiu Chioncel | S. Greene | Savina Nodari
[1] G. Fonarow,et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2007, American heart journal.
[2] K. Swedberg,et al. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. , 2013, Journal of the American College of Cardiology.
[3] Y. Sakata,et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[4] M. Gheorghiade,et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. , 2011, American heart journal.
[5] C. Yancy,et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. , 2006, Journal of the American College of Cardiology.
[6] E. Braunwald,et al. Hospitalizations for heart failure in the United States--a sign of hope. , 2011, JAMA.
[7] C. O'connor,et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.
[8] M. Gheorghiade,et al. Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction , 2011, Evidence Based Medicine.
[9] François Alla,et al. Heart failure burden and therapy. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] P. Ponikowski,et al. EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) , 2010, European journal of heart failure.
[11] D. Grobbee,et al. Angiotensin converting enzyme inhibition and hospitalisation rates for heart [letter] , 2002 .
[12] M. Gheorghiade,et al. The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes , 2011, Heart Failure Reviews.
[13] I. Piña,et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.
[14] C. Phillips,et al. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. , 2008, The American journal of cardiology.
[15] M. Gheorghiade,et al. Strategies and opportunities for drug development in heart failure. , 2013, JAMA.
[16] C. O'connor,et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). , 2008, The American journal of cardiology.
[17] C. O'connor,et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, American heart journal.
[18] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.
[19] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[20] Perry M. Elliott,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[21] P. Ponikowski,et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry , 2013, European journal of heart failure.
[22] P. Ponikowski,et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.
[23] M. Cheitlin. Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF Program , 2009 .
[24] G. Fonarow,et al. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE‐HF , 2012, European journal of heart failure.
[25] William T. Abraham,et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .
[26] C. Phillips,et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. , 2007, Journal of the American College of Cardiology.
[27] K. Swedberg,et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. , 2008, JAMA.
[28] Sanjiv J Shah,et al. Heart failure with preserved ejection fraction: treat now by treating comorbidities. , 2008, JAMA.
[29] V. Hasselblad,et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. , 2004, Journal of the American College of Cardiology.
[30] C. O'connor,et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. , 2010, American heart journal.
[31] G. Fonarow,et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2006, Journal of cardiac failure.
[32] A. Laupacis,et al. Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study , 2004 .
[33] C. O'connor,et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). , 2007, Archives of internal medicine.
[34] K. Adams,et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.
[35] W. Frishman,et al. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure , 2007 .
[36] Monica R. Shah,et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .
[37] J. McMurray,et al. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? , 2001, European heart journal.
[38] Christopher M O'Connor,et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.
[39] L. Tavazzi,et al. Acute heart failure patient profiles, management and in‐hospital outcome: results of the Italian Registry on Heart Failure Outcome , 2012, European journal of heart failure.
[40] G. Fonarow,et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2007, American heart journal.
[41] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[42] L. Dušek,et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry , 2011, Critical care.
[43] Wan Azman Wan Ahmad,et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). , 2012, Journal of cardiac failure.
[44] Javed Butler,et al. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. , 2011, Journal of cardiac failure.
[45] K. Swedberg,et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. , 2008, Journal of the American College of Cardiology.
[46] G. Fonarow,et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE‐HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) * , 2008, European journal of heart failure.
[47] I. Piña,et al. Heart failure in women: a need for prospective data. , 2009, Journal of the American College of Cardiology.
[48] G. Boriani,et al. A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[49] C. O'connor,et al. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). , 2008, The American journal of cardiology.
[50] M. Gheorghiade,et al. Heart failure in 2010: One step forward, two steps back , 2011, Nature Reviews Cardiology.
[51] Gerasimos Filippatos,et al. Epidemiology of acute heart failure syndromes , 2007, Heart Failure Reviews.
[52] C. O'connor,et al. Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study. , 2003, American heart journal.
[53] Piotr Ponikowski,et al. EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.
[54] M. Drazner,et al. Characteristics and outcomes in African American patients with decompensated heart failure. , 2008, Archives of internal medicine.
[55] G. Fonarow,et al. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). , 2009, The American journal of cardiology.
[56] V. Hasselblad,et al. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). , 2004, The American journal of cardiology.
[57] M. Gheorghiade,et al. The potential role of cardiac resynchronization therapy in acute heart failure syndromes , 2011, Heart Failure Reviews.
[58] J. Butler,et al. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. , 2003, Journal of the American College of Cardiology.
[59] R. Wexler. Early physician follow-up and 30-day readmission among older patients with heart failure. , 2010, JAMA.
[60] G. Ogedegbe,et al. Heart failure–associated hospitalizations in the United States. , 2013, Journal of the American College of Cardiology.
[61] M. Vaduganathan,et al. The disconnect between phase II and phase III trials of drugs for heart failure , 2013, Nature Reviews Cardiology.
[62] Harlan M Krumholz,et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. , 2011, JAMA.
[63] Nancy M Albert,et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.
[64] D. Grobbee,et al. Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? , 2002, Heart.
[65] L. Schwamm,et al. Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure. , 2009, American heart journal.
[66] G. Fonarow,et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.
[67] A. Cohen-Solal,et al. Clinical profile, contemporary management and one‐year mortality in patients with severe acute heart failure syndromes: The EFICA study ☆ , 2006, European journal of heart failure.
[68] Adrian F Hernandez,et al. Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes , 2012, Circulation.
[69] G. Fonarow,et al. Cardiac troponin and outcome in acute heart failure. , 2008, The New England journal of medicine.
[70] C. Yancy,et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. , 2010, JAMA.
[71] R. Bonow,et al. Postdischarge assessment after a heart failure hospitalization: the next step forward. , 2010, Circulation.
[72] R. Porcher,et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) , 2011, Intensive Care Medicine.
[73] Kevin L. Thomas,et al. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. , 2011, American heart journal.
[74] J. Piccini,et al. Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions , 2011, Heart Failure Reviews.
[75] D. Mozaffarian,et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.
[76] G. Fonarow,et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. , 2008, Journal of the American College of Cardiology.
[77] C. Yancy,et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). , 2007, American heart journal.
[78] K. Adams,et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, Journal of the American College of Cardiology.
[79] William T. Abraham,et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis , 2005 .
[80] K. Swedberg,et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. , 2003, European Heart Journal.
[81] Eliot Corday,et al. Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report from the ADHERE Registry , 2005, Heart Failure Reviews.
[82] G. Filippatos,et al. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. , 2012, European heart journal.
[83] Deepak L. Bhatt,et al. Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart Failure: An Analysis of Get With The Guidelines–Heart Failure , 2012, Circulation. Heart failure.
[84] M. Vaduganathan,et al. Thirty-day readmissions: the clock is ticking. , 2013, JAMA.
[85] G. Fonarow,et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. , 2007, Journal of cardiac failure.
[86] R. Bonow,et al. Heart failure: Early follow-up after hospitalization for heart failure , 2010, Nature Reviews Cardiology.
[87] D. J. Veldhuisen,et al. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions , 2014, Heart Failure Reviews.
[88] G. Fonarow,et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, Journal of the American College of Cardiology.
[89] Mark D. Huffman,et al. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.
[90] Deepak L. Bhatt,et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. , 2012, American heart journal.
[91] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.